J&J | JNJ - Stock


J&J reported $15.14B in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Abbott USD 6.99B 501M Mar/2026
Amgen USD 6.22B 34M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Bayer EUR 12.01B 321M Mar/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
CONMED USD 360.18M 5.93M Jun/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Globus Medical USD 810.9M 38.3M Jun/2026
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
J&J USD 15.14B 561M Jun/2026
Medtronic USD 6.31B 153M Dec/2025
Merck USD 6.21B 272M Jun/2026
Merit Medical Systems USD 374.11M 21.73M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026
Zoetis USD 2.57B 24M Jun/2026